Omeprazole Towa

Omeprazole, the active ingredient in Omeprazole Towa, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Omeprazole Towa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Towa is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Omeprazole Towa may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during early treatment. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased gas formation. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Hypomagnesemia: low blood magnesium levels, potentially causing muscle cramps or arrhythmia. - Acute interstitial nephritis: inflammation of kidney tissue. - Stevens‑Johnson syndrome: rare skin and mucous membrane disorder. - Liver enzyme elevation: increased ALT/AST indicating hepatic stress. - Fracture risk: potential reduction in bone mineral density with long‑term use.

Before starting Omeprazole Towa, consider the following safety measures: - Assess renal function: adjust use if chronic kidney disease. - Evaluate hepatic status: use cautiously in liver impairment. - Review concomitant medications: check for drugs that require acidic pH for absorption. - Monitor long‑term therapy: periodic assessment for bone health and magnesium levels. - Pregnancy and lactation: weigh benefits against potential risks; consult a healthcare professional. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture.

Omeprazole Towa can affect the pharmacokinetics of several medicines. Awareness of these interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity, increasing cardiovascular event risk. - Atazanavir: markedly decreased absorption, compromising HIV treatment. - Dasatinib: lowered plasma concentrations, reducing anticancer efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring closer coagulation monitoring. - Phenytoin: may raise serum levels, risking toxicity. - Digoxin: possible elevation of serum digoxin concentrations. - Ketoconazole: reduced absorption due to higher gastric pH.